Biotechs rise in early trading as the death toll from the new avian flu strain jumps to 13. Sinovac (SVA) is preparing immunizations and can manufacture 30-40M doses annually, according to Bloomberg. Meanwhile, investors continue to bet BioCryst's (BCRX) peramavir could have a role to play. Premarket moves: SVA +9.6%, BCRX +7.4%, NVAX +5%.
Biotechs rise in early trading as the death toll from the new avian flu strain jumps to 13....
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs